Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...

Full description

Bibliographic Details
Main Authors:	Hsing-Fang Lu, Po-Hsin Chou, Gan-Hong Lin, Wan-Hsuan Chou, Shih-Tien Wang, Wirawan Adikusuma, Eko Mugiyanto, Kuo-Sheng Hung, Wei-Chiao Chang
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.1155/2020/8855423

Similar Items

The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
by: Enrico M Messalli, et al.
Published: (2009-04-01)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
by: Fujiwara S, et al.
Published: (2014-11-01)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
by: Chen M, et al.
Published: (2016-03-01)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
by: Yeesuk Kim, et al.
Published: (2020-07-01)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
by: Darb&agrave; J, et al.
Published: (2013-07-01)

Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
by: Nagai N, et al.
Published: (2018-09-01)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
by: Vogel VG
Published: (2011-10-01)

Concerns on modeling postmenopausal osteoporosis on young female rats
by: Pavlos Lelovas, et al.
Published: (2019-12-01)

Pharmacogenomics in osteoporosis: Steps toward personalized medicine
by: Robert Greene, et al.
Published: (2009-09-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Association between alendronate v.s raloxifene and esophageal diseases among patients with osteoporosis
by: Szu-Chia Tu, et al.
Published: (2012)

The Association between Cardiovascular Events and the Use of Osteoporosis Medications- Alendronate vs. Raloxifene
by: Pei-Yu Lu, et al.

New treatment paradigm of combined raloxifene and conjugated estrogen for postmenopausal symptoms in VCD-ind
by: Marwa N. Emam, et al.
Published: (2017-08-01)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)

Hypercalciuria in Postmenopausal Osteoporosis
by: Ayfer Kanberoğlu, et al.
Published: (2004-06-01)

The treatment of postmenopausal osteoporosis
by: Middleton, Edward Thomas
Published: (2008)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
by: Horia Lăzărescu, et al.
Published: (2019-09-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
by: Victor G Vogel
Published: (2008-12-01)

New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis
by: Amira K. Khalifa, et al.
Published: (2020-01-01)

Primary osteoporosis in postmenopausal women
by: Meng-Xia Ji, et al.
Published: (2015-03-01)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

HYPERTENSION AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Marina Rašić Popović, et al.
Published: (2009-04-01)

Immunologic Aspects of Postmenopausal Osteoporosis
by: V.V. Povoroznyuk, et al.
Published: (2013-08-01)

Bazedoxifene for the prevention of postmenopausal osteoporosis
by: Luigi Gennari, et al.
Published: (2008-09-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Treatment options for postmenopausal osteoporosis
by: Walsh GM
Published: (2012-08-01)

Genetic epidemiology of postmenopausal osteoporosis
by: Keen, Richard William
Published: (2000)

Response to Letter to the Editor: Concerns on modeling postmenopausal osteoporosis in young female rats
by: Juan Marcelo Rosales Rocabado, et al.
Published: (2019-12-01)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
by: Tiao Lin, et al.
Published: (2014-01-01)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
by: Junmei Cairns, et al.
Published: (2020-08-01)

Long-Term Treatment of Postmenopausal Osteoporosis
by: Jacques P. Brown
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_3q39ks2mitsmsfb4gjg9fmt3ls